 |
            |
Program
Download AKIN Brochure

|
|
TUESDAY, June
10, 2008
|
| 3:00pm
|
Registration Opens - Ballroom A & B
|
| 3:00pm
|
AKIN Advisory Committee Meeting
|
| 5:00pm
|
Registration Opens
|
| 6:00pm
|
Welcome Reception - Poster Session
Faculty and Fellows Reception
|
|
|
WEDNESDAY, June 11, 2008
|
| 7:00am
|
Registration Opens - Ballroom A & B
|
| 7:00-7:30am
|
Breakfast
|
| 7:30am
|
Opening Remarks
Ravindra Mehta, MD, FACP
|
|
|
|
| PLENARY 1
Understanding Pathophysiology and Targeting Therapy in
AKI
Co-Chairs: Anupam Agarwal, MD and Hamid Rabb, MD
|
|
|
|
| 7:30-8:00am
|
Cell Types, Their Roles and Interactions
in AKI
Joseph Bonventre, MD
|
| 8:00-8:30am
|
Cellular Processes Involved in
AKI:
Injury, Inflammation, Apoptosis, Repair
Mark Okusa, MD
|
| 8:30-9:00am
|
Key Signaling Pathways as Potential Targets in AKI: p53, Hif, AMPK, mTOR etc.
Simon Atkinson, PhD
|
| 9:00-9:30am
|
Macro and Microvascular Considerations
in AKI?
Matthieu Legrand, MD
|
| 9:30-10:00am
|
Panel Discussion
Moderator: Prasad Devarajan, MD
|
| 10:00-10:30am
|
Coffee Break
|
|
|
|
| PLENARY 2
Research In Progress in AKI
Summary of current status of research recommendations from
AKIN 2
Co-Chairs: Raul Lombardi, MD and Steve Webb, MD
|
|
|
|
| 10:30-10:50am
|
Validation of Diagnostic and Staging
Criteria
Dinna Cruz, MD MPH
|
| 10:50-11:10am
|
Biomarker Studies In AKI
Bertrand L. Jaber, MD, FASN
|
| 11:10-11:30am
|
Epidemiology of AKI
Neesh Pannu, MD
|
| 11:30-11:50am
|
Prevention Trials in AKI
Peter A. McCullough, MD, MPH
|
| 11:50-12:10pm
|
Intervention Trials in AKI: Non-Dialysis
Zoltan Endre, MD
|
| 12:10-12:30pm
|
Dialysis Trials in AKI
Paul Palevsky, MD
|
| 12:30-1:00pm
|
Panel Discussion
Moderator: Patrick Murray, MD
|
| 1:00-2:00pm
|
Lunch Hosted by Conference
KEY NOTE LECTURE
AKI Research and Translation What's Needed
Robert Schrier, MD
|
CONCURRENT WORKSHOPS
Reports from each workshop will be presented in Plenary 3 starting a 4:00pm
|
2:00-3:30pm
|
Workshop 1
Coding Issues in AKI
Co-Chairs: Michael Joannidis, MD and David G. Warnock, MD
|
|
|
|
|
|
This workshop will discuss
the need for common terminology and labeling of AKI
for the ICD-10 codes that are used internationally.
Proposals for new terminology of acute kidney
disease, staging of AKI and the relationship to chronic
kidney disease will be described. The process
by which the CKD CPT codes were developed will be reviewed
as a starting point. Using a similar approach, this
workshop will develop a consensus document for updating
the CPT codes for Acute Renal Failure so that the current
usage of Acute Kidney Disease and Acute Kidney Injury
are incorporated into the codes.
|
|
|
|
|
3:30-4:00
|
Coffee Break
|
|
|
Reports from this workshop
will take place in Plenary 3 at 4:00pm
|
|
| 2:00-3:30pm
|
Workshop 2
Raising Awareness of AKI
Co-Chairs: Adeera Levin, MD and Sudhir Shah, MD
|
|
|
|
|
|
This workshop will discuss
the need for and strategies to increase awareness of
AKI in the scientific and lay community. Various approaches
utilized for other diseases will be presented and an
action plan for AKI developed.
|
|
|
|
| 3:30-4:00
|
Coffee Break
|
|
|
Reports from this workshop
will take place in Plenary 3 at 4:20pm
|
|
| 2:00-3:30pm
|
Workshop 3
Research Priorities in AKI: Involving Industry
Chair: Bruce Molitoris, MD and Andrew Shaw, MD
|
|
|
|
|
|
This workshop will explore
the opportunities for developing partnerships and collaborations
among industry and academic and public institutions
to facilitate research in AKI. Strategies Prioritized
areas for AKI research based on need will be identified
and a plan for implementation developed.
|
|
|
|
| 3:30-4:00
|
Coffee Break
|
|
|
Reports from this workshop
will take place in Plenary 3 at 4:40pm
|
|
| 2:00-3:30pm
|
Workshop 4
AKIN Activities and Research Base Enhancement
Co-Chairs: Adeera Levin, MD and Ravindra L. Mehta, MD, FACP
|
|
|
|
|
|
This workshop will describe
the current organization and activities of AKIN and
discuss various opportunities to further enhance existing
resources and the research base and facilitate participation
from members, supporting societies and industry.
|
|
|
|
| 3:30-4:00
|
Coffee Break
|
|
|
Reports from of this workshop
will take place in Plenary 3 at 5:00pm
|
|
| PLENARY 3
Reports From Workshops
Moderator: TBA |
|
|
|
| 4:00-4:20pm |
Report From Workshop 1
|
| 4:20-4:40pm |
Report From Workshop 2
|
| 4:40-5:00pm |
Report From Workshop 3
|
| 5:00-5:20pm |
Report From Workshop 4 |
| 5:20-6:00pm |
Panel Discussion
|
| 6:00pm |
Adjourn
|
| 6:15pm |
Transportation to Reception & Dinner starts departing
|
| 7:00pm |
Networking Reception & Conference Dinner
|
| |
|
|
|
THURSDAY, June 12, 2008
|
| 7:00am
|
Registration Opens - Ballroom A & B
|
| 7:00-7:30am
|
Breakfast
|
| PLENARY 4
AKI Studies with Available Funding
Co-Chairs: Mathew Breyer, MD and Ravi Vishwanathan,
MD
|
| 10 min. Sessions
|
|
| 7:30-7:40am
|
Biosite
Peter McCullough, MD
|
| 7:40-7:50am
|
Biotrin Biomarkers
Cormac Kilty, MD
|
| 7:50-8:00am
|
CMIC Co., Ltd
Yasushi Takigawa
|
| 8:00-8:10am
|
CorMedix
Mark Houser, MD MBA
|
| 8:10-8:20am
|
Flowmedica
Jeff Elkins
|
| 8:20-8:30am
|
Gambro
William R. Clark, MD
|
| 8:30-8:40am
|
LiDCO, Limited
Rick Alberts
|
| 8:40-8:50am
|
MedDynamix
Mor Grinstein
|
| 8:50-9:00am
|
Merck Research Laboratories
David Gerhold, PhD
|
| 9:00-9:10am
|
NxStage
Emil Paganini, MD
|
| 9:10-9:20am
|
Quark
Shai Erlich, PhD
|
| 9:20-9:30am
|
Thrasos
Richard Andrews
|
| 9:30-9:45am
|
Coffee Break
|
|
|
|
| PLENARY 5
Future Directions
Co-Chairs: Roland Blantz, MD and Robert Schrier, MD
|
|
|
|
| 9:45-10:15am
|
Stem Cell Therapy for AKI: An Update
Christof Westenfelder, MD
|
| 10:15-10:45am
|
Role of NIH in Supporting AKI Research
Robert Star, MD
|
| 10:45-11:15am
|
FDA Perspective
Aliza Thompson, MD
|
| 11:15-11:45am
|
The Industry Perspective
Karen Smirnakis, MD, PhD, MPH
|
| 11:45am-12:15pm
|
Venture Capital
Étienne Lagacé
|
| 12:15pm-12:45pm
|
Panel Discussion
Moderator: Sudhir Shah, MD
|
| 12:45pm
|
Conference Adjourns
|
| 12:45-1:35pm
|
Lunch Hosted by Conference
|
|
|
|